TABLE 3B.

Associations between therapeutic AC use and length of hospital stay in the total cohort and the propensity score (PS)‐matched cohort

	Total cohort					PS‐matched cohort
	Therapeutic AC use (n = 190)		No therapeutic AC use (n = 964)			Therapeutic AC use (n = 164)		No therapeutic AC use (n = 410)
Length of hospital stay	Days	(IQR)	Days	(IQR)	P‐value	Days	(IQR)	Days	(IQR)	P‐value
All patients	7.0	(4.0–11.0)	7.0	(4.0–13.0)	.47	7.0	(4.3–11.8)	7.0	(4.0–12.0)	.69
Deceased
Yes	6.0	(4.0–9.0)	7.0	(5.0–12.0)	.06	6.5	(4.0–10.8)	7.0	(4.0–10.0)	.61
No	7.0	(5.0–13.0)	7.0	(4.0–13.0)	.51	7.0	(5.0–12.8)	7.0	(4.0–12.0)	.40

AC = anticoagulation, IQR = interquartile range.

^a The propensity scores included the following characteristics: age, sex, body mass index, active malignancy, chronic pulmonary disease, diabetes mellitus, hypertension, obstructive coronary artery disease, myocardial infarction, heart failure, nonischaemic cardiomyopathy, previous heart surgery, electronic heart device, cerebrovascular accident, peripheral artery disease, immunosuppressive medication, no ICU policy.